MedTrace Logo

Study of Chlorhexidine Gluconate as a Preoperative Antisepsis

NCT01495117 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 534

Last updated 2016-12-21

No results posted yet for this study

Summary

The purpose of this study is to determine which drug (chlorhexidine gluconate vs. povidone iodine) as a preoperative antisepsis in clean-contaminated abdominal surgery (liver, hepatobiliary, small or large bowel, stomach) is effective.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Povidone-Iodine

7.5% povidone iodine soaping 10% povidone iodine painting

DRUG

Chlorhexidine gluconate

4% chlorhexidine gluconate soaping 2% chlorhexidine gluconate painting

Sponsors & Collaborators

  • Seung Duk Lee

    lead OTHER_GOV

Principal Investigators

  • Sung-Sik Han, Ph.D. · Liver Cancer Center, National Cancer Center, Republic of Korea

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01495117 on ClinicalTrials.gov